Сравнение

Buserelin vs. Carbetocin

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

57982-77-1

37025-55-1

Молекулярная масса

1239.42 g/mol

нет данных

Период полувыведения

нет данных

0.67 h

Последовательность

нет данных

Механизм действия

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Carbetocin

Carbetocin is an oxytocin receptor agonist with prolonged duration. It triggers a sustained contraction of the uterus after birth, preventing atonic hemorrhage — unlike oxytocin, without a multi-hour infusion.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Buserelin	Carbetocin
Германия	Рецептурный	Рецептурный
США	Не одобрено	Не одобрено

Полные записи

Frequently asked questions

What is the difference between Buserelin and Carbetocin?: Buserelin is classified as "Исследования (прочее)", while Carbetocin is classified as "Исследования (прочее)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Carbetocin?: The highest available evidence level is "РКИ на людях" for Buserelin and "РКИ на людях" for Carbetocin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Carbetocin in Germany and the United States?: Германия: Buserelin — Рецептурный, Carbetocin — Рецептурный. США: Buserelin — Не одобрено, Carbetocin — Не одобрено. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Carbetocin

Германия

Рецептурный

США

Не одобрено

Frequently asked questions

What is the difference between Buserelin and Carbetocin?

Buserelin is classified as "Исследования (прочее)", while Carbetocin is classified as "Исследования (прочее)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Carbetocin?

The highest available evidence level is "РКИ на людях" for Buserelin and "РКИ на людях" for Carbetocin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Carbetocin in Germany and the United States?

Германия: Buserelin — Рецептурный, Carbetocin — Рецептурный. США: Buserelin — Не одобрено, Carbetocin — Не одобрено. These are factual summaries with source and review date on the individual pages.